Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effectiveness of Booster Doses of the SARS-CoV-2 Inactivated Vaccine KCONVAC against the Mutant Strains

12 Sept 2022

Abstract excerpt

As the COVID-19 epidemic progresses with the emergence of different SARS-CoV-2 variants, it is important to know the effectiveness of inactivated SARS-CoV-2 vaccines against the variants. To maximize efficiency, a third boost injection of the high-dose SARS-CoV-2 inactivated vaccine KCONVAC was selected for investigation. In addition to the ancestral strain, KCONVAC boost vaccination induced neutralizing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to Vaccine Coverage and Hesitancy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36146822
DOI: 10.3390/v14092016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 17 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effectiveness of Booster Doses of the SARS-CoV-2 Inactivated Vaccine KCONVAC against the Mutant StrainsPMID 36146822Read ↗

From Wuhan to Omicron K.P2 strain: A comprehensive review of SARS-CoV-2 phylogeny and public health implications of the latest booster vaccine.Semantic proximity Read ↗

Vaccine efficacy in mutant SARS-CoV-2 variants.Semantic proximity Read ↗

The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines.Semantic proximity Read ↗

A Heterologous V-01 or Variant-Matched Bivalent V-01D-351 Booster following Primary Series of Inactivated Vaccine Enhances the Neutralizing Capacity against SARS-CoV-2 Delta and Omicron StrainsSemantic proximity Read ↗

The vaccines can keep up with the SARS-CoV-2 mutations.Semantic proximity Read ↗

The Efficacy for the Booster Dose of Covid-19 Vaccine between Sars-Cov-2 Omicron Variant and a Two-Year Longitudinal Antibody on Wild Type ConvalescentsSemantic proximity Read ↗

A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccinesSemantic proximity Read ↗

Sequential immunization with SARS-CoV-2 RBD vaccine induces potent and broad neutralization against variants in miceSemantic proximity Read ↗

Antibody neutralization to SARS-CoV-2 and variants after one year in WuhanSemantic proximity Read ↗

Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination SchedulesSemantic proximity Read ↗

Rational design of a booster vaccine against COVID-19 based on antigenic distanceSemantic proximity Read ↗

Effectiveness of Covid-19 Vaccines against the SARS-COV-2-Delta (B.1.617.2) in China-A Real World StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.